Pantoprazole – safety in drug-drug interaction by E. V. Shikh, D. A. Sychev

“…Data of investigations, available for the present time, in vitro and in vivo allow to consider pantoprazole (Nolpaza) as the most safe drug for application in complex therapy to reduce the drug interaction-associated adverse effects.…”
Get full text

Healthy Living: Are You at Risk for Drug Interactions? by Jennifer Hillan, Linda B. Bobroff

“…Bobroff, provides a list of 9 questions to help people determine whether they are at risk of drug interactions. Published by the UF Department of Family Youth and Community Sciences, August 2010.     …”
Get full text

Healthy Living: Are You at Risk for Drug Interactions? by Jennifer Hillan, Linda B. Bobroff

“…Bobroff, provides a list of 9 questions to help people determine whether they are at risk of drug interactions. Published by the UF Department of Family Youth and Community Sciences, August 2010.     …”
Get full text

The drugs, interacting with opiate receptors, and their application in gastroenterological practice by S. A. Bulgakov

“…Conclusion. The drugs interacting with opiate receptors, are widely used in gastroenterological practice and there are preconditions to broaden spectrum of these agents.…”
Get full text

Healthy Living for Elders: Are You at Risk for Drug Interactions? by Jennifer Hillan

“…To see if you are at risk for drug interactions, circle Yes or No for the questions provided in this document. …”
Get full text

Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors by Amber N. Edinoff, Connor R. Swinford, Amira S. Odisho, Caroline R. Burroughs, Cain W. Stark, Walid A. Raslan, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye

Get full text

Healthy Living for Elders: Are You at Risk for Drug Interactions? by Jennifer Hillan

“…To see if you are at risk for drug interactions, circle Yes or No for the questions provided in this document. …”
Get full text

Potential QT-prolonging drug-drug interactions in cardiovascular disease patients by Milena Kovačević, Milica Ćulafić, Marija Jovanović, Sandra Vezmar Kovačević, Katarina Vučićević, Branislava Miljković, Predrag Stevanović, Slavica Radovanović

Subjects: Get full text

Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism by Marte Svalastoga, Trine-Lise Larsen, Trine-Lise Larsen, Jorunn Brekke, Tone Enden, Hege Frøen, Herish Garresori, Eva Marie Jacobsen, Alina Carmen Porojnicu, Anne Hansen Ree, Anne Hansen Ree, Dag Torfoss, Elin Osvik Velle, Hilde Skuterud Wik, Waleed Ghanima, Waleed Ghanima, Per Morten Sandset, Per Morten Sandset, Anders Erik Astrup Dahm, Anders Erik Astrup Dahm

Subjects: Get full text

Nurses’ Knowledge Regarding FoodDrug Interaction in the Intensive Care and Emergency Hospitals by Samir Y Lafi, Aram Salih Mohammed Amin Kamali, Bayan Omar Sharif

Subjects: “…Food-Drug Interaction, knowledge, Intensive Care Unit, Shar and Emergency Hospitals…”
Get full text

Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data? by Paul Moayyedi, Daniel C Sadowski

Get full text

Metabolic Characteristics of Oxcarbazepine (®Trileptal) and their Beneficial Implications for Enzyme Induction and Drug Interactions by Johann W. Faigle, Guenter P. Menge

“…On the whole, OXC possesses very little potential for metabolic drug interactions, and thus differs favourably from other anti-epileptic drugs.…”
Get full text

Ginkgo biloba L.: An Updated Review on the Pharmacological Activities, Pharmacokinetics and Drug Interactions by Zahra Moeinipour, Maryam Akaberi, Zahra Sobhani

Subjects: Get full text

Hospitalization due to Adverse Drug Reactions and Drug Interactions before and after HAART by Michelle M Foisy, Kevin Gough, Corinna M Quan, Kevin Harris, Dominique Ibanez, Anne Phillips

Get full text

Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures by Ebere C. Anyanwu, Andrew W. Campbell, John E. Ehiri

Get full text

Investigation of Herb-Drug Interactions between Xylopia aethiopica, Its Principal Constituent Xylopic Acid, and Antidepressants by Christian C. Ndu, Wonder K. M. Abotsi, Priscilla K. Mante

“…One of the factors causing patients to not attain therapeutic goals is herb-drug interactions. Objective. To investigate any potential herb-drug interaction that might exist between Xylopia aethiopica extract (XAE) or xylopic acid (XA) and selected conventional antidepressants (imipramine, fluoxetine, and venlafaxine) in mice. …”
Get full text

An in-vivo herb-drug interaction study of IME-9 and glimepiride in nicotinamide-STZ-induced diabetic rats by Archana K. Thikekar, Asha B. Thomas, Sohan S. Chitlange

Get full text

Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions by Verbič Matej Dobravc, Brvar Miran, Kos Mojca Kerec

Subjects: Get full text

Drug-Drug interactions prediction calculations between cardiovascular drugs and antidepressants for discovering the potential co-medication risks. by Tie Hua Zhou, Tian Yu Jin, Xi Wei Wang, Ling Wang

“…Predicting Drug-Drug Interactions (DDIs) enables cost reduction and time savings in the drug discovery process, while effectively screening and optimizing drugs. …”
Get full text